EGR1 and esophageal cancer: The EGR-1 expression was reported to increase in TE2 esophageal cancer (TE2) cells compared with other esophageal cell lines, and knockdown of EGR-1 could increase 4E-BP1 expression in TE2 cells, which became sensitive to rapamycin treatment [10].